2025
Acceptability of long-acting antiretroviral therapy among people living with HIV who use drugs in Vancouver, Canada: A qualitative study
Chayama K, Ng C, Brohman I, Mansoor M, Small W, Philbin M, Collins A, McNeil R. Acceptability of long-acting antiretroviral therapy among people living with HIV who use drugs in Vancouver, Canada: A qualitative study. PLOS ONE 2025, 20: e0319010. PMID: 40019916, PMCID: PMC11870339, DOI: 10.1371/journal.pone.0319010.Peer-Reviewed Original ResearchConceptsAdherence to antiretroviral therapyLong-acting antiretroviral therapyLA-ARTAntiretroviral therapySuboptimal adherence to antiretroviral therapyAdherence barriersProspective cohort studySuboptimal ART adherenceAdverse side effectsPill burdenTreatment optionsSubstance useCohort studyART adherenceTreatment advancesSide effectsTreatment changesPLHIVTreatment approachesTherapyCredible sources of informationPopulation-level benefitsDrugHIVSocial-structural inequities
2024
‘It just doesn't stop’: Perspectives of women who use drugs on increased overdoses during the COVID‐19 pandemic
Speed K, McNeil R, Hayashi K, Maher L, Boyd J. ‘It just doesn't stop’: Perspectives of women who use drugs on increased overdoses during the COVID‐19 pandemic. Drug And Alcohol Review 2024, 44: 602-612. PMID: 39703005, PMCID: PMC11813672, DOI: 10.1111/dar.13996.Peer-Reviewed Original ResearchConceptsGender violenceSocio-economic marginalisationOverdose crisisDrug supplyPerspective of womenViolence frameworkExacerbate harmStructural driversSemi-structured interviewsViolenceCOVID-19 pandemicRisk of overdoseSocial distancing guidelinesReduced opportunitiesCrisisCOVID-19Health crisisOverdose riskWomenDistancing guidelinesIndividualised approachPublic health guidanceIncreasing overdoseHarmCOVID-19 environment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply